ID

36268

Beschreibung

Phase I, Dose Escalation Study of Decitabine; ODM derived from: https://clinicaltrials.gov/show/NCT02264873

Link

https://clinicaltrials.gov/show/NCT02264873

Stichworte

Versionen (1)
  1. 27.04.19 27.04.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

27. April 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Leukemia, Lymphoblastic, Acute NCT02264873

Englisch

Eligibility Leukemia, Lymphoblastic, Acute NCT02264873

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
age: greater than 1 and less than 31 years of age;
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis: history of all, aml or mds, currently in a complete remission (cr) following allo-hsct (bone marrow leukemic blasts less than 5% by morphology), with high risk features including:
Beschreibung

Acute lymphocytic leukemia | Leukemia, Myelocytic, Acute | MYELODYSPLASTIC SYNDROME | In complete remission Following Allogeneic Hematopoietic Stem Cell Transplantation | Bone Marrow Leukemic Blast Count | Feature High risk

Datentyp

boolean

Alias
UMLS CUI [1]
C0023449
UMLS CUI [2]
C0023467
UMLS CUI [3]
C3463824
UMLS CUI [4,1]
C0677874
UMLS CUI [4,2]
C0332282
UMLS CUI [4,3]
C1705576
UMLS CUI [5,1]
C0005953
UMLS CUI [5,2]
C2697913
UMLS CUI [6,1]
C2348519
UMLS CUI [6,2]
C4319571
status post allogeneic hsct
Beschreibung

Status post Allogeneic Hematopoietic Stem Cell Transplantation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C1705576
gvhd prophylaxis:
Beschreibung

Prophylaxis against graft versus host disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1096407
karnofsky or lansky performance scores more than 50%. karnofsky scores will be used for patients > 16 years of age and lansky scores for patients ≤ 16 years of age;
Beschreibung

Karnofsky Performance Status | Lansky Play-Performance Status | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0206065
UMLS CUI [2]
C1522275
UMLS CUI [3]
C0001779
platelet count ≥ 50,000 (untransfused);
Beschreibung

Platelet Count measurement | Transfusion Absent

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
UMLS CUI [2,1]
C1879316
UMLS CUI [2,2]
C0332197
absolute neutrophil count ≥ 1000; and;
Beschreibung

Absolute neutrophil count

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
hemoglobin ≥ 8 g/dl (un-transfused);
Beschreibung

Hemoglobin measurement | Transfusion Absent

Datentyp

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2,1]
C1879316
UMLS CUI [2,2]
C0332197
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
progressive disease;
Beschreibung

Progressive Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1335499
philadelphia chromosome positive all (these patients receive tyrosine kinase inhibitor posttransplant);
Beschreibung

Philadelphia positive acute lymphocytic leukaemia | Tyrosine kinase inhibitor therapy Post Transplantation

Datentyp

boolean

Alias
UMLS CUI [1]
C4524071
UMLS CUI [2,1]
C0879484
UMLS CUI [2,2]
C0687676
UMLS CUI [2,3]
C0040732
known hypersensitivity to any components of decitabine;
Beschreibung

Hypersensitivity Decitabine Component

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0049065
UMLS CUI [1,3]
C1705248
uncontrolled grade 3-4 graft versus host disease;
Beschreibung

Graft-vs-Host Disease Grade Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0018133
UMLS CUI [1,2]
C0441800
UMLS CUI [1,3]
C0205318
uncontrolled infection;
Beschreibung

Communicable Disease Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
serum creatinine > 2 mg/dl or glomerular filtration rate (gfr) less than 60 ml/min/1.73m2 ;
Beschreibung

Creatinine measurement, serum | Glomerular Filtration Rate

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0017654
alanine aminotransferase (alt) greater than 3 times normal or serum total bilirubin greater than 2 mg/dl;
Beschreibung

Alanine aminotransferase increased | Serum total bilirubin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0151905
UMLS CUI [2]
C1278039
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Leukemia, Lymphoblastic, Acute NCT02264873

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age: greater than 1 and less than 31 years of age;
boolean
C0001779 (UMLS CUI [1])
Acute lymphocytic leukemia | Leukemia, Myelocytic, Acute | MYELODYSPLASTIC SYNDROME | In complete remission Following Allogeneic Hematopoietic Stem Cell Transplantation | Bone Marrow Leukemic Blast Count | Feature High risk
Item
diagnosis: history of all, aml or mds, currently in a complete remission (cr) following allo-hsct (bone marrow leukemic blasts less than 5% by morphology), with high risk features including:
boolean
C0023449 (UMLS CUI [1])
C0023467 (UMLS CUI [2])
C3463824 (UMLS CUI [3])
C0677874 (UMLS CUI [4,1])
C0332282 (UMLS CUI [4,2])
C1705576 (UMLS CUI [4,3])
C0005953 (UMLS CUI [5,1])
C2697913 (UMLS CUI [5,2])
C2348519 (UMLS CUI [6,1])
C4319571 (UMLS CUI [6,2])
Status post Allogeneic Hematopoietic Stem Cell Transplantation
Item
status post allogeneic hsct
boolean
C0231290 (UMLS CUI [1,1])
C1705576 (UMLS CUI [1,2])
Prophylaxis against graft versus host disease
Item
gvhd prophylaxis:
boolean
C1096407 (UMLS CUI [1])
Karnofsky Performance Status | Lansky Play-Performance Status | Age
Item
karnofsky or lansky performance scores more than 50%. karnofsky scores will be used for patients > 16 years of age and lansky scores for patients ≤ 16 years of age;
boolean
C0206065 (UMLS CUI [1])
C1522275 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Platelet Count measurement | Transfusion Absent
Item
platelet count ≥ 50,000 (untransfused);
boolean
C0032181 (UMLS CUI [1])
C1879316 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Absolute neutrophil count
Item
absolute neutrophil count ≥ 1000; and;
boolean
C0948762 (UMLS CUI [1])
Hemoglobin measurement | Transfusion Absent
Item
hemoglobin ≥ 8 g/dl (un-transfused);
boolean
C0518015 (UMLS CUI [1])
C1879316 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Progressive Disease
Item
progressive disease;
boolean
C1335499 (UMLS CUI [1])
Philadelphia positive acute lymphocytic leukaemia | Tyrosine kinase inhibitor therapy Post Transplantation
Item
philadelphia chromosome positive all (these patients receive tyrosine kinase inhibitor posttransplant);
boolean
C4524071 (UMLS CUI [1])
C0879484 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C0040732 (UMLS CUI [2,3])
Hypersensitivity Decitabine Component
Item
known hypersensitivity to any components of decitabine;
boolean
C0020517 (UMLS CUI [1,1])
C0049065 (UMLS CUI [1,2])
C1705248 (UMLS CUI [1,3])
Graft-vs-Host Disease Grade Uncontrolled
Item
uncontrolled grade 3-4 graft versus host disease;
boolean
C0018133 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
Communicable Disease Uncontrolled
Item
uncontrolled infection;
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Creatinine measurement, serum | Glomerular Filtration Rate
Item
serum creatinine > 2 mg/dl or glomerular filtration rate (gfr) less than 60 ml/min/1.73m2 ;
boolean
C0201976 (UMLS CUI [1])
C0017654 (UMLS CUI [2])
Alanine aminotransferase increased | Serum total bilirubin measurement
Item
alanine aminotransferase (alt) greater than 3 times normal or serum total bilirubin greater than 2 mg/dl;
boolean
C0151905 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video